FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
This is the first update to the original CTS communication distributed on July 6th. As previously co...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
We are very excited to launch our new website! Please take a few moments to click around and explore...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...